跳至主要内容
临床试验/NCT03778125
NCT03778125Unknown不适用

Clinical and Microbiologic Outcomes in Patients Treated for Multidrug-resistant Shigella Infections in Dhaka, Bangladesh

University of Virginia1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2018年12月13日最近更新:
适应症

试验速览

阶段
不适用
入组人数
2,000
试验地点
1
主要终点
Clinical outcome: resolution of diarrhea

研究概览

简要总结

The purpose of this project is to systematically collect clinical and nutritional outcomes information on patients treated for Shigella infection so that physicians and clinical laboratories can better define which Shigella infections are "resistant" to antibiotics and which are "susceptible", focusing on azithromycin a last-line drug to treat drug resistant Shigella

详细描述

2000 suspected Shigella cases will be recruited from International Centre for Diarrhoeal Disease Research hospital, Dhaka who are presenting with diarrhea at the hospital. A stool sample will be collected from the participants after consenting by the study staff. Stool microscopy will be performed to see the white blood cells(WBC) and red blood cells (RBC). If WBC > 10 HPF (4) with any RBC present, culture will be performed from this stool to identify Shigella. Such patients with invasive diarrhea are treated with azithromycin per local standard of care. Enrolled participant will be invited for further follow up when culture from the stool is Shigella positive. Minimal inhibitory concentration (MIC) testing of Shigella isolates and Molecular testing of Shigella isolates will be performed from Shigella cultures. This is an observational study. This study does not provide any treatment to the study participants; they will receive treatment as per International Centre for Diarrhoeal Disease Research Dhaka hospital guidelines. We will then examine the effect of the azithromycin minimal inhibitory concentration on clinical outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • diarrheal illness less than 96 hours duration
  • microscopic evidence of inflammatory diarrhea
  • plus mucus in stool
  • plus abdominal pain/cramps
  • Subject or parents or legal guardian willing to come for follow up at hospital or allow study staff for home visit
  • residence in Dhaka region
  • presentation during daytime hours

排除标准

  • Not receiving treatment with azithromycin at enrolment

结局指标

主要结局

Clinical outcome: resolution of diarrhea

时间窗: Day 5

resolution of diarrhea as measured by the participant through a memory aid

次要结局

  • Proportion of patients that have complications(day 5)
  • Microbiologic outcome: Shigella negative cultures(Day 5)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric R. Houpt, MD

Jack Gwaltney Professor of Infectious Diseases

University of Virginia

研究点 (1)

Loading locations...

相似试验

Multidrug Resistant Shigella Infection in Bangladesh | 临床试验